Item 7.01 Regulation FD Disclosure.

On September 7, 2022, CEN Biotech Inc. (the "Company") issued a press release (the "Press Release"). The Press Release announces the commencement of trading of the Company's common shares on the OTCQB Venture Market® beginning on September 8, 2022 and also provides a business update. The Press Release is furnished hereto as Exhibit 99.1 and is incorporated by reference herein. The information contained in the Press Release is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that Section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.



Exhibit No.   Description
99.1**          Press Release dated September 7,
              2022.
104           Cover Page Interactive Data File
              (embedded within the Inline XBRL
              document)

**Furnished herewith.

© Edgar Online, source Glimpses